Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059276
Filing Date
2025-04-28
Accepted
2025-04-28 16:01:09
Documents
15
Period of Report
2025-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A mgx-20250425.htm   iXBRL DEF 14A 742015
2 GRAPHIC img244680343_0.jpg GRAPHIC 246742
3 GRAPHIC img244680343_1.jpg GRAPHIC 463317
4 GRAPHIC img244680343_2.jpg GRAPHIC 414013
  Complete submission text file 0000950170-25-059276.txt   3595947

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mgx-20250425.xsd EX-101.SCH 36767
18 EXTRACTED XBRL INSTANCE DOCUMENT mgx-20250425_htm.xml XML 7632
Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Filer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41949 | Film No.: 25880113
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)